IBDEI2U8 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,45266,1,4,0)
;;=4^C50.911
;;^UTILITY(U,$J,358.3,45266,2)
;;=^5001195
;;^UTILITY(U,$J,358.3,45267,0)
;;=C64.1^^172^2261^13
;;^UTILITY(U,$J,358.3,45267,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45267,1,3,0)
;;=3^Malignant neoplasm of right kidney, except renal pelvis
;;^UTILITY(U,$J,358.3,45267,1,4,0)
;;=4^C64.1
;;^UTILITY(U,$J,358.3,45267,2)
;;=^5001248
;;^UTILITY(U,$J,358.3,45268,0)
;;=C44.99^^172^2261^14
;;^UTILITY(U,$J,358.3,45268,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45268,1,3,0)
;;=3^Malignant neoplasm of skin,Oth Spec
;;^UTILITY(U,$J,358.3,45268,1,4,0)
;;=4^C44.99
;;^UTILITY(U,$J,358.3,45268,2)
;;=^5001094
;;^UTILITY(U,$J,358.3,45269,0)
;;=C79.51^^172^2261^15
;;^UTILITY(U,$J,358.3,45269,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45269,1,3,0)
;;=3^Secondary malignant neoplasm of bone
;;^UTILITY(U,$J,358.3,45269,1,4,0)
;;=4^C79.51
;;^UTILITY(U,$J,358.3,45269,2)
;;=^5001350
;;^UTILITY(U,$J,358.3,45270,0)
;;=C79.52^^172^2261^16
;;^UTILITY(U,$J,358.3,45270,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45270,1,3,0)
;;=3^Secondary malignant neoplasm of bone marrow
;;^UTILITY(U,$J,358.3,45270,1,4,0)
;;=4^C79.52
;;^UTILITY(U,$J,358.3,45270,2)
;;=^5001351
;;^UTILITY(U,$J,358.3,45271,0)
;;=D47.4^^172^2262^29
;;^UTILITY(U,$J,358.3,45271,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45271,1,3,0)
;;=3^Osteomyelofibrosis
;;^UTILITY(U,$J,358.3,45271,1,4,0)
;;=4^D47.4
;;^UTILITY(U,$J,358.3,45271,2)
;;=^5002259
;;^UTILITY(U,$J,358.3,45272,0)
;;=D50.9^^172^2262^1
;;^UTILITY(U,$J,358.3,45272,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45272,1,3,0)
;;=3^Anemia, iron deficiency
;;^UTILITY(U,$J,358.3,45272,1,4,0)
;;=4^D50.9
;;^UTILITY(U,$J,358.3,45272,2)
;;=^5002283
;;^UTILITY(U,$J,358.3,45273,0)
;;=D64.9^^172^2262^2
;;^UTILITY(U,$J,358.3,45273,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45273,1,3,0)
;;=3^Anemia, unspecified
;;^UTILITY(U,$J,358.3,45273,1,4,0)
;;=4^D64.9
;;^UTILITY(U,$J,358.3,45273,2)
;;=^5002351
;;^UTILITY(U,$J,358.3,45274,0)
;;=D75.89^^172^2262^3
;;^UTILITY(U,$J,358.3,45274,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45274,1,3,0)
;;=3^Blood & blood forming organ disease, oth spec
;;^UTILITY(U,$J,358.3,45274,1,4,0)
;;=4^D75.89
;;^UTILITY(U,$J,358.3,45274,2)
;;=^5002392
;;^UTILITY(U,$J,358.3,45275,0)
;;=D89.2^^172^2262^16
;;^UTILITY(U,$J,358.3,45275,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45275,1,3,0)
;;=3^Hypergammaglobulinemia, unspecified
;;^UTILITY(U,$J,358.3,45275,1,4,0)
;;=4^D89.2
;;^UTILITY(U,$J,358.3,45275,2)
;;=^5002455
;;^UTILITY(U,$J,358.3,45276,0)
;;=E03.9^^172^2262^24
;;^UTILITY(U,$J,358.3,45276,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45276,1,3,0)
;;=3^Hypothyroidism, unspecified
;;^UTILITY(U,$J,358.3,45276,1,4,0)
;;=4^E03.9
;;^UTILITY(U,$J,358.3,45276,2)
;;=^5002476
;;^UTILITY(U,$J,358.3,45277,0)
;;=E05.90^^172^2262^30
;;^UTILITY(U,$J,358.3,45277,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45277,1,3,0)
;;=3^Thyrotoxicosis w/o thyrotoxic crisis/storm
;;^UTILITY(U,$J,358.3,45277,1,4,0)
;;=4^E05.90
;;^UTILITY(U,$J,358.3,45277,2)
;;=^5002492
;;^UTILITY(U,$J,358.3,45278,0)
;;=E08.42^^172^2262^10
;;^UTILITY(U,$J,358.3,45278,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45278,1,3,0)
;;=3^DM d/t underlying condition w/ diabetic polyneuropathy
;;^UTILITY(U,$J,358.3,45278,1,4,0)
;;=4^E08.42
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2U8 3785 printed Nov 22, 2024@17:46:05 Page 2
IBDEI2U8 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,45266,1,4,0)
+2 ;;=4^C50.911
+3 ;;^UTILITY(U,$J,358.3,45266,2)
+4 ;;=^5001195
+5 ;;^UTILITY(U,$J,358.3,45267,0)
+6 ;;=C64.1^^172^2261^13
+7 ;;^UTILITY(U,$J,358.3,45267,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,45267,1,3,0)
+10 ;;=3^Malignant neoplasm of right kidney, except renal pelvis
+11 ;;^UTILITY(U,$J,358.3,45267,1,4,0)
+12 ;;=4^C64.1
+13 ;;^UTILITY(U,$J,358.3,45267,2)
+14 ;;=^5001248
+15 ;;^UTILITY(U,$J,358.3,45268,0)
+16 ;;=C44.99^^172^2261^14
+17 ;;^UTILITY(U,$J,358.3,45268,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,45268,1,3,0)
+20 ;;=3^Malignant neoplasm of skin,Oth Spec
+21 ;;^UTILITY(U,$J,358.3,45268,1,4,0)
+22 ;;=4^C44.99
+23 ;;^UTILITY(U,$J,358.3,45268,2)
+24 ;;=^5001094
+25 ;;^UTILITY(U,$J,358.3,45269,0)
+26 ;;=C79.51^^172^2261^15
+27 ;;^UTILITY(U,$J,358.3,45269,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,45269,1,3,0)
+30 ;;=3^Secondary malignant neoplasm of bone
+31 ;;^UTILITY(U,$J,358.3,45269,1,4,0)
+32 ;;=4^C79.51
+33 ;;^UTILITY(U,$J,358.3,45269,2)
+34 ;;=^5001350
+35 ;;^UTILITY(U,$J,358.3,45270,0)
+36 ;;=C79.52^^172^2261^16
+37 ;;^UTILITY(U,$J,358.3,45270,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,45270,1,3,0)
+40 ;;=3^Secondary malignant neoplasm of bone marrow
+41 ;;^UTILITY(U,$J,358.3,45270,1,4,0)
+42 ;;=4^C79.52
+43 ;;^UTILITY(U,$J,358.3,45270,2)
+44 ;;=^5001351
+45 ;;^UTILITY(U,$J,358.3,45271,0)
+46 ;;=D47.4^^172^2262^29
+47 ;;^UTILITY(U,$J,358.3,45271,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,45271,1,3,0)
+50 ;;=3^Osteomyelofibrosis
+51 ;;^UTILITY(U,$J,358.3,45271,1,4,0)
+52 ;;=4^D47.4
+53 ;;^UTILITY(U,$J,358.3,45271,2)
+54 ;;=^5002259
+55 ;;^UTILITY(U,$J,358.3,45272,0)
+56 ;;=D50.9^^172^2262^1
+57 ;;^UTILITY(U,$J,358.3,45272,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,45272,1,3,0)
+60 ;;=3^Anemia, iron deficiency
+61 ;;^UTILITY(U,$J,358.3,45272,1,4,0)
+62 ;;=4^D50.9
+63 ;;^UTILITY(U,$J,358.3,45272,2)
+64 ;;=^5002283
+65 ;;^UTILITY(U,$J,358.3,45273,0)
+66 ;;=D64.9^^172^2262^2
+67 ;;^UTILITY(U,$J,358.3,45273,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,45273,1,3,0)
+70 ;;=3^Anemia, unspecified
+71 ;;^UTILITY(U,$J,358.3,45273,1,4,0)
+72 ;;=4^D64.9
+73 ;;^UTILITY(U,$J,358.3,45273,2)
+74 ;;=^5002351
+75 ;;^UTILITY(U,$J,358.3,45274,0)
+76 ;;=D75.89^^172^2262^3
+77 ;;^UTILITY(U,$J,358.3,45274,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,45274,1,3,0)
+80 ;;=3^Blood & blood forming organ disease, oth spec
+81 ;;^UTILITY(U,$J,358.3,45274,1,4,0)
+82 ;;=4^D75.89
+83 ;;^UTILITY(U,$J,358.3,45274,2)
+84 ;;=^5002392
+85 ;;^UTILITY(U,$J,358.3,45275,0)
+86 ;;=D89.2^^172^2262^16
+87 ;;^UTILITY(U,$J,358.3,45275,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,45275,1,3,0)
+90 ;;=3^Hypergammaglobulinemia, unspecified
+91 ;;^UTILITY(U,$J,358.3,45275,1,4,0)
+92 ;;=4^D89.2
+93 ;;^UTILITY(U,$J,358.3,45275,2)
+94 ;;=^5002455
+95 ;;^UTILITY(U,$J,358.3,45276,0)
+96 ;;=E03.9^^172^2262^24
+97 ;;^UTILITY(U,$J,358.3,45276,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,45276,1,3,0)
+100 ;;=3^Hypothyroidism, unspecified
+101 ;;^UTILITY(U,$J,358.3,45276,1,4,0)
+102 ;;=4^E03.9
+103 ;;^UTILITY(U,$J,358.3,45276,2)
+104 ;;=^5002476
+105 ;;^UTILITY(U,$J,358.3,45277,0)
+106 ;;=E05.90^^172^2262^30
+107 ;;^UTILITY(U,$J,358.3,45277,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,45277,1,3,0)
+110 ;;=3^Thyrotoxicosis w/o thyrotoxic crisis/storm
+111 ;;^UTILITY(U,$J,358.3,45277,1,4,0)
+112 ;;=4^E05.90
+113 ;;^UTILITY(U,$J,358.3,45277,2)
+114 ;;=^5002492
+115 ;;^UTILITY(U,$J,358.3,45278,0)
+116 ;;=E08.42^^172^2262^10
+117 ;;^UTILITY(U,$J,358.3,45278,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,45278,1,3,0)
+120 ;;=3^DM d/t underlying condition w/ diabetic polyneuropathy
+121 ;;^UTILITY(U,$J,358.3,45278,1,4,0)
+122 ;;=4^E08.42
